MedCity News

MedCity Influencers

Work Requirements Put New Pressure On Medicaid Member Retention

By John Marchisin

Health Tech

Willow Acquires 2 Women’s Health Companies

Willow Innovations acquired Swehl and Momtech to expand its maternal health offerings beyond breast pumps.

By Marissa Plescia

Sponsored Post

How Can Hospitals and Pharmacists Collaborate on Effective Stewardship Programs for Opioids and Antibiotics?

A webinar sponsored by Inovalon explored how hospitals and pharmacies can work together to generate the best outcomes for patients while improving patient safety.

By Stephanie Baum

BioPharma, Pharma

Patient Deaths and Data Shortfall Spell the End for Cell Therapy Biotech Artiva

Artiva Biotherapeutics attributed one of the fatalities to a drug used to prepare patients for cell therapy and not to the cell therapy itself. But Artiva’s setbacks follow safety signals reported for autoimmune disease cell therapy programs from Novartis and Bristol Myers Squibb.

By Frank Vinluan

Latest Video

Latest News

Payers, Health Tech, Providers

ClarityCare Raises $16.5M to Speed Up Prior Authorizations 

As health plans grapple with new federal deadlines for prior authorization decisions, healthcare AI startup ClarityCare has raised $16.5 million to automate the administrative workload that can keep patients waiting for the care they need.

By Jenna Congdon

MedCity Influencers

A Market, Not a Mandate, Is the Fastest Way to Bring AI Into Hospitals

The cost of waiting is not evenly distributed. Rural and critical access hospitals report under 50 percent adoption of even basic predictive tools, compared with 86 percent among top-tier system-affiliated hospitals. Every year without a bridge widens that gap, and it widens it fastest for the hospitals with the least room to absorb it.

By Dr. Andrew M. Ibrahim

presented by

Sponsored Post

The Healthcare Payments Industry Faces a Perception Challenge

Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.

By Lisa Brooks, Vice President, Healthcare Partnerships

Policy

How Experts Are Reacting to Trump’s Women’s Health Executive Order

Women’s health experts had mixed reactions to the Trump administration's executive order on women's health.

By Marissa Plescia

BioPharma, Pharma

Obesity Biotech Corxel Is Going Public in a Merger as Oral GLP-1 Heads to Phase 3

Corxel Pharmaceuticals is catching up to others with oral GLP-1 obesity drugs, but the biotech claims its small molecule could offer better tolerability compared to the rest of its class. The SPAC merger taking Corxel public is expected to close in the first half of 2027, which is when the biotech plans to start a Phase 3 trial.

By Frank Vinluan

Hospitals, Devices & Diagnostics

Sutter Health Expands Remote Monitoring Program to Patients with Heart Failure

Sutter Health, a nonprofit healthcare system based in Sacramento, California, is expanding its digital chronic disease management program, Sutter Sync, to include patients with heart failure. The expansion adds a remote monitoring technology from San Francisco-based medical tech company Bodyport. The program expansion comes as health systems look for ways to identify deterioration in a low acuity environment before patients reach the point of needing emergency hospitalization.

By Jenna Congdon

presented by

Sponsored Post, Artificial Intelligence

Automation Didn’t Dehumanize Care. Bad Systems Did.

We have the opportunity to design systems that give people greater capacity for the work where human presence matters most: listening, understanding, reassuring, deciding, and caring.

By Michael Blackman, MD, MBA Chief Medical Officer, Greenway Health®

MedCity Influencers

In a Maternity Care Crisis, CMS Undermines Efforts To Modernize Care

CMS has introduced uncertainty about whether Medicare will participate in that modernization or preserve the old system under a different name. The consequences extend far beyond billing

By Mark N. Simon

Sponsored Post, BioPharma

FDA Alignment Is a Starting Point, Not a Rare Disease Strategy for the European Market

For US biotech companies developing rare disease therapies, decisions about clinical evidence, patient populations and regulatory advice can have consequences in Europe long before a marketing application is submitted.

By Stephanie Baum

presented by

Sponsored Post

Inside an Automated Healthcare Practice: Redesigning Care Around People, Not Paperwork 

By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.

By Michael Blackman, MD, MBA Chief Medical Officer, Greenway Health®

Health Tech

CareValidate Launches Expanded HRT Offering

CareValidate expanded its HRT offering for telehealth companies, combining hormone therapy with provider access, pharmacy services and AI-powered care coordination.

By Marissa Plescia

BioPharma, Pharma

Lycia Lands a $317M IPO for Inflammation Drugs Based on Nobel Prize-Winning Science

Lycia Therapeutics’ protein-degrading drugs are based on the research of Carolyn Bertozzi, a Stanford chemistry professor and Nobel laureate. Lycia’s lead drug candidate is in development for food allergy, where it could compete against the blockbuster Roche drug Xolair.

By Frank Vinluan

MedCity Influencers, Hospitals

Congress’s Patient Matching Fix Won’t Work — Here’s What Would

The MATCH IT Act aims to reduce patient matching errors. But a model used by vital records systems could provide a better solution.

By Nidhi Singh

MedCity Influencers

Physician Mental Health and Health System Privacy: Why Doctors Avoid Their Own EHR

In most organizations the default access model was built for patient care, not for protecting colleagues. A nurse on another unit, a resident who rotated with them, a department administrator: any of them may technically be able to open the record, even when policy says they should not.

By Elijah Fernandez

Devices & Diagnostics

Fractyl’s Weight Maintenance Device Meets Clinical Goal, but Shares Nosedive, Layoffs Follow

Fractyl Health reported positive six-month trial results from an investigation of its Revita procedure last week, but shares of Fractyl stock dropped steeply on October 16 immediately following the announcement. Despite the positive findings, the stock’s sharp decline highlighted a contrast between the clinical findings and the market’s response.

By Jenna Congdon

Health Tech

Where Are the Biggest Opportunities in Women’s Cardiovascular Health?

MedTech Conference panelists cited inflammation research, listening to women, clinical trial representation and investment as priorities for women’s cardiovascular health.

By Marissa Plescia

BioPharma, Pharma

Gilead to Pay $1.3B for Oral Peptide That Could Rival J&J’s New Immunology Pill

Gilead Sciences is getting global rights to an experimental PepStar Therapeutics oral peptide designed to inhibit the IL-23 receptor to treat inflammatory bowel disease. It could compete against Johnson & Johnson’s Icotyde, an oral peptide that blocks the same target and is also in development for IBD.

By Frank Vinluan

MedCity Influencers

Why an Independent NP Practice Requires an Undergraduate Business Foundation

Ultimately, while clinical training teaches nurses how to care for patients within a system, business education empowers them to design, protect, and scale the system.

By Octavia “Tavi” Schlueter